- Home
- WHLR vs NLSP Comparison
WHLR vs NLSP Comparison
Compare WHLR & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- NLSP
- Stock Information
- Founded
- WHLR 2011
- NLSP 2015
- Country
- WHLR United States
- NLSP Switzerland
- Employees
- WHLR N/A
- NLSP N/A
- Industry
- WHLR Real Estate Investment Trusts
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- NLSP Health Care
- Exchange
- WHLR Nasdaq
- NLSP Nasdaq
- Market Cap
- WHLR 7.5M
- NLSP 6.2M
- IPO Year
- WHLR 2012
- NLSP 2021
- Fundamental
- Price
- WHLR $2.47
- NLSP $1.91
- Analyst Decision
- WHLR
- NLSP
- Analyst Count
- WHLR 0
- NLSP 0
- Target Price
- WHLR N/A
- NLSP N/A
- AVG Volume (30 Days)
- WHLR 4.6M
- NLSP 2.2M
- Earning Date
- WHLR 03-04-2025
- NLSP 10-18-2024
- Dividend Yield
- WHLR N/A
- NLSP N/A
- EPS Growth
- WHLR N/A
- NLSP N/A
- EPS
- WHLR N/A
- NLSP N/A
- Revenue
- WHLR $102,749,000.00
- NLSP N/A
- Revenue This Year
- WHLR N/A
- NLSP N/A
- Revenue Next Year
- WHLR N/A
- NLSP N/A
- P/E Ratio
- WHLR N/A
- NLSP N/A
- Revenue Growth
- WHLR N/A
- NLSP N/A
- 52 Week Low
- WHLR $2.28
- NLSP $1.73
- 52 Week High
- WHLR $1,144.80
- NLSP $20.80
- Technical
- Relative Strength Index (RSI)
- WHLR 29.17
- NLSP 41.47
- Support Level
- WHLR $2.28
- NLSP $1.87
- Resistance Level
- WHLR $4.80
- NLSP $2.08
- Average True Range (ATR)
- WHLR 0.65
- NLSP 0.27
- MACD
- WHLR 0.23
- NLSP 0.03
- Stochastic Oscillator
- WHLR 7.54
- NLSP 8.77
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.